| Literature DB >> 33312297 |
Luciano Ragone1, João Guilherme Vieira2, Mateus Camaroti Laterza2, Luis Leitão3, Jefferson da Silva Novaes4, Jeferson Macedo Vianna2, Marcelo Ricardo Dias1.
Abstract
The purpose of the present study was to verify the acute effect of sodium bicarbonate supplementation on symptoms of gastrointestinal discomfort, acid-base balance and intermittent isometric handgrip test performance in Jiu-Jitsu athletes. Ten male (22.2 ± 3.9 years; 174 ± 0.07 cm; 74.5 ± 8.9 kg) jiu-jitsu athletes participated in this counterbalanced double-blind crossover study. Two protocols, a) supplementation with 0.3 g.kg-1 of body weight of sodium bicarbonate, and b) supplementation with 0.045 g.kg-1 of body weight of placebo substance, were employed. Gastrointestinal tolerability was assessed by the questionnaire. Blood samples were collected at three time points (baseline, pre-ISO, and post-ISO) to determine the responses of potential hydrogenionic (pH), bicarbonate (HCO3- ), base excess (EB) and lactate concentrations. The maximum voluntary contraction test and the intermittent isometric contraction test were also performed. As a result, none of the athletes reported significant gastrointestinal discomfort (p > 0.05). HCO3- , pH, and EB at the pre-ISO and post-ISO moments were significantly higher for the sodium bicarbonate protocol. Lactate concentrations were significantly higher for both post-ISO protocols (p = 0.000). There was no significant difference in the performance of the maximum voluntary contraction test and the intermittent isometric contraction test (p > 0.05). Thus, we conclude that sodium bicarbonate supplementation does not generate adverse responses resulting in gastrointestinal discomfort, and does not benefit performance yet promotes a state of metabolic alkalosis.Entities:
Keywords: NaHCO3; handgrip exercise; intermittent exercise; martial arts; metabolic alkalosis
Year: 2020 PMID: 33312297 PMCID: PMC7706673 DOI: 10.2478/hukin-2020-0039
Source DB: PubMed Journal: J Hum Kinet ISSN: 1640-5544 Impact factor: 2.193
Figure 1Experimental design of the study
Incidence of gastrointestinal distress symptoms (GI) 20, 40 and 60 minutes after sodium bicarbonate (NaHCO3) and placebo (NaCl) supplementation protocols.
| NaHCO3- | NaCl | |||||||
|---|---|---|---|---|---|---|---|---|
| Baseline | 20-PS | 40-PS | 60-PS | Baseline | 20-OS | 40-OS | 60-OS | |
| Nausea | 0.25±0.87 | 0.50±1.17 | 0.25±0.87 | 0.25±0.87 | 0.00±0.00 | 0.50±1.73 | 0.25±0.87 | 0.25±0.87 |
| Stomach cramps | 0.00±0.00 | 0.75±1.86 | 0.25±0.87 | 0.25±0.87 | 0.00±0.00 | 0.50±1.73 | 0.25±0.87 | 0.25±0.87 |
| Flatulence | 0.50±1.17 | 2.00±2.34 | 1.00±1.48 | 1.25±2.38 | 0.50±1.17 | 1.75±2.01 | 1.00±1.48 | 1.25±2.01 |
| Belching | 0.50±1.17 | 2.50±2.50 | 2.75±1.36 | 1.00±1.48 | 1.25±0.87 | 2.25±2.26 | 1.00±1.48 | 0.25±0.87 |
| Bloating | 1.25±2.54 | 3.75±2.90 | 2.25±2.26 | 1.25±2.01 | 1.75±2.38 | 3.00±3.13 | 2.25±2.26 | 2.00±1.95 |
| Diarrhea | 0.50± .17 | 1.25±2.70 | 0.50±1.17 | 0.75±1.36 | 0.00±0.00 | 1.25±2.01 | 0.25±0.87 | 1.00±1.48 |
Data expressed as mean ± standard deviation.
Blood variables (hydrogenionic potential (pH), bicarbonate (HCO3), excess base (EB), and lactate) baseline, pre-ISO and post-ISO for the sodium bicarbonate (NaHCO3), and placebo (NaCl) protocols.
| NaHCO3- | NaCl | △ difference | 95% CI | ||
|---|---|---|---|---|---|
| pH (unit) | |||||
| Baseline | 7.35 ± 0.01 | 7.35 ± 0.02 | 0.00 | -0.01–0.01 | 0.970 |
| Pre-ISO | 7.40 ± 0.01*‡ | 7.35 ± 0.02 | 0.06 | 0.03-0.07 | 0.000 |
| Post-ISO | 7.33 ± 0.04†‡ | 7.28 ± 0.02*† | 0.04 | 0.01-0.07 | 0.006 |
| HCO3- (mmol∙L-1) | |||||
| Baseline | 26.32 ± 1.22# | 24.76 ± 1.13 | 1.63 | 0.64-2.48 | 0.004 |
| Pre-ISO | 29.96 ± 1.88*‡ | 24.61 ± 0.93 | 5.31 | 3.69-7.00 | 0.000 |
| Post-ISO | 26.87 ± 2.13†‡ | 22.01 ± 1.33*† | 4.84 | 2.61-7.10 | 0.001 |
| EB (mmol∙L-1) | |||||
| Baseline | -0.37 ± 0.64 | -0.61 ± 0.65 | 0.34 | -0.18-0.67 | 0.229 |
| Pre-ISO | 3.98 ±1.33*‡ | -1.08 ± 0.99 | 3.03 | 3.83-6.31 | 0.000 |
| Post-ISO | -0.26 ± 2.34†‡ | -4.50 ± 1.76*† | 4.28 | 1.77-6.69 | 0.004 |
| Lactate (mmol∙L-1) | |||||
| Baseline | 1.57 ± 0.28 | 1.40 ± 0.22 | 0.10 | -0.04-0.38 | 0.101 |
| Pre-ISO | 1.38 ± 0.45 | 1.47 ± 0.47 | 0.09 | -0.49-0.32 | 0.661 |
| Post-ISO | 5.23 ± 1.47*† | 4.87 ± 0.87*† | 0.30 | -0.46-1.18 | 0.348 |
Data expressed as mean ± standard deviation; * Significant difference from baseline values (p < 0.05); † Significant difference from pre-ISO (p < 0.05); ‡ Significant difference from the NaCl protocol (p < 0.05).
Exercise performance of the maximum voluntary contraction test (MVC) and intermittent isometric contraction test (ISO) for the sodium bicarbonate (NaHCO3) and placebo (NaCl) protocols.
| NaHCO3- | NaCl | △ difference | 95% CI | ||
|---|---|---|---|---|---|
| MVC Test | |||||
| Maximum (Kgf) | 44.40 ± 12.55 | 44.40 ± 11.48 | 0.13 | -1.65-1.65 | 1.000 |
| Average (Kgf) | 40.08 ± 12.32 | 40.21 ± 10.75 | 0.13 | -1.89-1.69 | 0.903 |
| ISO Test | |||||
| Total contractions (reps) | 56.20 ± 27.69 | 55.30 ± 31.49 | 0.90 | -21.54-32.34 | 0.930 |
| Total time (min) | 9.35 ± 4.62 | 9.22 ± 5.25 | 0.15 | -3.60-3.87 | 0.938 |
Data expressed as mean ± standard deviation.